Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Allotrope Foundation Reaches First Major Milestone in Development of Laboratory Information Framework and Launch of Partner Network

Published: Sunday, March 30, 2014
Last Updated: Sunday, March 30, 2014
Bookmark and Share
Allotrope Foundation aims to make the intelligent analytical laboratory a reality.

Allotrope Foundation, a consortium of pharmaceutical and biotech companies, has reached the first major milestone in the development of its innovative laboratory information Framework and announced the launch of a partner network to encourage further collaboration.

In just six months, the Foundation has gone from concept to implementation of its first Proof of Concept (PoC) application using the open Framework that will manage analytical data throughout its complete lifecycle using a common set of standard tools.

Allotrope has also established a Partner Network, designed to enable and encourage collaboration with the instrument and software vendor community in developing the Framework.

“The deployment of the first Proof of Concept is a significant milestone on our development roadmap”, said Wolfgang Colsman, CTO of Osthus GmbH and lead architect of the Allotrope Framework. “In about six months of development, we were able to go from an idea to a working implementation.”

Allotrope Foundation aims to make the intelligent analytical laboratory a reality – an automated laboratory where data, methods and hardware components are seamlessly shared between disparate platforms, and where one-click reports can be produced using data generated on any analytical instrument. The Proof of Concept now deployed addresses experiment initiation and data acquisition using instruments from multiple vendors (standard instrument input-output). This PoC also demonstrates the seamless exchange of analytical data between software applications from different vendors. This state-of-the-art data exchange demonstrates several new capabilities, including the simple exchange of data between an Allotrope member and a business partner, for example, a CRO.

“I am really excited to be part of this historic event and of our contribution to bringing the longstanding vision of the intelligent analytical lab one step closer to a reality,” said Janet Cheetham, Executive Director, Analytical Research and Development at Amgen and Board Member of Allotrope. “Seeing the Framework perform as expected in one of our own laboratories validates the core fundamentals of Allotrope’s approach to solving many of the current pain points we are experiencing today with analytical data management in Pharma Biotech and in many other industries that have analytical labs.”

“From the onset of Allotrope Foundation, we’ve been focused on building a sustainable Framework that will enhance how we produce and consume analytical data,” said James Roberts, Senior Scientific Investigator, Analytical Development at GlaxoSmithKline (GSK) and co-lead of the Allotrope Foundation Core Technical Team. “Using the Framework to embed open standards in our labs, running real experiments in 2014, is the first step to enhancing efficiency, facilitating data exchange and enabling automation.”

The successful deployment of a Proof of Concept also triggers the launch of Allotrope’s Partner Network, which is designed to give all software and hardware vendors an opportunity to provide direct feedback to Allotrope Foundation regarding the Framework.

“We took great care to design a Partner Network that enables all interested vendors to provide feedback on the Framework,” said Gordon Hansen, VP Analytical Development, US and Chairman of Allotrope Foundation Board of Directors. “There has been strong interest from the vendor community in working with us, and we are thrilled to open the doors to such a collaboration.”

As part of the Partner Network, Allotrope provides access to pre-release software, documentation, interfaces and test data.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!